Edwards Lifesciences Corporation ( EW) - Stock Earnings
EW Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| July 23, 2026 AfterMarket | — / — | — | — / — | — |
EW Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 291.1 million USD | 1.6 billion USD |
| 2025Q4 | 91.2 million USD | 1.6 billion USD |
| 2026Q1 | 380.7 million USD | 1.6 billion USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
EW Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 1.4 billion USD | 6.0 billion USD |
| 2024 | 4.2 billion USD | 5.4 billion USD |
| 2025 | 1.1 billion USD | 6.1 billion USD |
| 2026 Est. | — | — |
EW
Price: $84.37
Earnings Per Share: 1.85 USD
P/E Ratio: 43.90
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 2.2 million
Ebitda: 328.1 millionMarket Capitalization: 54.3 billion